263 related articles for article (PubMed ID: 21126902)
1. Lipids, lipid-lowering therapy and diabetes complications.
Valensi P; Picard S
Diabetes Metab; 2011 Feb; 37(1):15-24. PubMed ID: 21126902
[TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
Steinmetz A
Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
[TBL] [Abstract][Full Text] [Related]
3. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
Dodson PM
Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
Wanner C; Krane V
Kidney Blood Press Res; 2011; 34(4):209-17. PubMed ID: 21691123
[TBL] [Abstract][Full Text] [Related]
5. Therapies for diabetic dyslipidaemia.
Bell DS; Al Badarin F; O'Keefe JH
Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
[TBL] [Abstract][Full Text] [Related]
6. Role for fibrate therapy in diabetes: evidence before FIELD.
Vergès B
Curr Opin Lipidol; 2005 Dec; 16(6):648-51. PubMed ID: 16276243
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
Jones PH
Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
[TBL] [Abstract][Full Text] [Related]
8. Management of dyslipidemia in diabetes.
Solano MP; Goldberg RB
Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
[TBL] [Abstract][Full Text] [Related]
9. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
Soska V
Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414
[TBL] [Abstract][Full Text] [Related]
10. Combination lipid therapy in type 2 diabetes mellitus.
Vergès B
Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
[TBL] [Abstract][Full Text] [Related]
11. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
Betteridge J
Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
[TBL] [Abstract][Full Text] [Related]
12. The role of fenofibrate in clinical practice.
Zambon A; Cusi K
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056
[TBL] [Abstract][Full Text] [Related]
13. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Nicholls SJ; Lundman P; Tardif JC
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
[TBL] [Abstract][Full Text] [Related]
14. Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
Wierzbicki AS
Curr Opin Lipidol; 2010 Aug; 21(4):352-8. PubMed ID: 20625256
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
17. Summarizing the FIELD study: lessons from a 'negative' trial.
Tsimihodimos V; Mikhailidis DP; Elisaf M
Expert Opin Pharmacother; 2013 Dec; 14(18):2601-10. PubMed ID: 24206060
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate - a potential systemic treatment for diabetic retinopathy?
Wong TY; Simó R; Mitchell P
Am J Ophthalmol; 2012 Jul; 154(1):6-12. PubMed ID: 22709833
[TBL] [Abstract][Full Text] [Related]
19. Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?
Handelsman Y; Fonseca V; Rosenstock J
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):43-54. PubMed ID: 22142158
[TBL] [Abstract][Full Text] [Related]
20. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D
Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
